Picture of Deutsche Biotech Innovativ AG logo

DBI Deutsche Biotech Innovativ AG Income Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareMicro Cap

Annual income statement for Deutsche Biotech Innovativ AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
GAS
GAS
GAS
GAS
GAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.120000
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses0.2840.3980.3710.1970.207
Operating Profit-0.164-0.398-0.371-0.197-0.207
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.165-0.404-0.385-0.223-0.236
Provision for Income Taxes
Net Income After Taxes-0.165-0.404-0.385-0.223-0.236
Net Income Before Extraordinary Items
Net Income-0.165-0.404-0.385-0.223-0.236
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.165-0.404-0.385-0.223-0.236
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.175-0.427-0.407-0.236-0.25
Dividends per Share